SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Phibro Animal Health Corp (PAHC)

NASDAQ: PAHC · Real-Time Price · USD
37.72+1.11 (+3.03%)
 
Market Cap1.53B+0.3%
Revenue (ttm)1.52B
Net Income99.72M
EPS2.43
Shares Out21.11M
PE Ratio15.52
Forward PE9.82
Dividend$0.48(1.27%)
Ex-Dividend DateSep 2, 2026
Volume199,506
Open36.43
Previous Close36.61
Day's Range36.09 - 37.92
52-Week Range28.25 - 60.08
Beta0.42
AnalystsHold
Price Target44.00(+16.65%)
Earnings DateNov 4, 2026
+3.03% (1D)
No price history available.
Insider Score
––Not scored
PAHC Insider Score

Insiders here have filed 14 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About PAHC

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Address
Glenpointe Centre East, Teaneck, NJ, 07666-6712, United States
Market Cap
1.53 billion
Employees
2,605
Industrial Classification
Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$2.92M
Bought
$317.70K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+3.03%
5 Days
+5.54%
1 Month
+1.10%
6 Months
-35.70%
1 Year
+0.27%

$PAHC stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of PAHC by members of U.S. Congress

PoliticianTypeTraded
Michael T. McCaulHouse / RSale$1.00K – $15.00KSep 1, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KAug 30, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KMar 4, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KMar 2, 2022
Michael T. McCaulHouse / RSale$1.00K – $15.00KDec 14, 2021
Michael T. McCaulHouse / RPurchase$1.00K – $15.00KMar 4, 2021

Recently reported changes in PAHC holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PAHC's directors and management

Net Shares Purchased by Insiders−50k−25k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PAHC Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PAHC Revenue by Segment

$1.52BTotal
SegmentRevenue% of All
Animal Health$1.16B76.56%
Mineral Nutrition$282.34M18.60%
Performance Products$73.53M4.84%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-K)

U.S. Patents

New PAHC patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PAHC from public contracts

Source: USAspending.gov

PAHC Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for PAHC yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from PAHC’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
1
Sells
17
Buy Value
$317.70K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.